Literature DB >> 6232849

Hysteroscopic incision of the septate uterus.

R Israel, C M March.   

Abstract

Fifteen women underwent hysteroscopic incision of symptomatic septate uteri between April, 1982, and July, 1983. All procedures were performed on an outpatient basis with general anesthesia, by means of dextran hysteroscopy with direct-vision scissors incision of the septa under external laparoscopic guidance. No significant intraoperative nor postoperative complications occurred. Preoperative indications included repetitive pregnancy loss (eight), repetitive pregnancy loss and infertility (four), infertility and total uterine septum (one), preinsemination by donor (one), and intractable dysmenorrhea (one). A total of 72 hysteroscopic septal incision/resection procedures unassociated with any significant morbidity have been reported in the literature. Compared to transabdominal metroplasty, hysteroscopy is an outpatient procedure that avoids abdominal and uterine incisions and requires no long-term postoperative delay in attempting pregnancy. In addition, subsequent pregnancy does not require cesarean section. With these advantages, hysteroscopic incision of the symptomatic septate uterus can replace transabdominal metroplasty and allow liberalization of operative indications.

Entities:  

Mesh:

Year:  1984        PMID: 6232849     DOI: 10.1016/0002-9378(84)90293-x

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  3 in total

Review 1.  [Hysteroscopic surgery].

Authors:  R Kimmig
Journal:  Arch Gynecol Obstet       Date:  1995       Impact factor: 2.344

2.  Hysteroscopic metroplasty.

Authors:  H R McClelland
Journal:  Ulster Med J       Date:  1993-04

3.  Fertility and pregnancy outcomes following resectoscopic septum division with and without intrauterine balloon stenting: a randomized pilot study.

Authors:  Basim Fouad Abu Rafea; George Angelos Vilos; Ayman Mohamad Oraif; Stephen George Power; Jackie Hollet Cains; Angelos George Vilos
Journal:  Ann Saudi Med       Date:  2013 Jan-Feb       Impact factor: 1.526

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.